http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_86270fdbe46cb3b0a52f1e2bf6e72dba
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Mark Layton Layton |
| name | D. Mark Layton D Mark Layton |
| given-name | D Mark D. D. Mark |
| organization-name | Hammersmith Hospital, Imperial College Healthcare NHS Trust London UK Centre for Haematology, St Mary's Hospital Campus of Imperial College Faculty of Medicine St Mary's Hospital London UK Hammersmith Hospital Imperial College Healthcare NHS Trust London UK Department of Haematology Imperial College NHS Trust, Hammersmith Hospital London W12 0HS United Kingdom Department of Haematology St Mary's Hospital London W2 1NY UK; Centre for Haematology St Mary's Hospital campus of Imperial College London Faculty of Medicine, St Mary's Hospital London W2 1NY UK Department of Haematology, Hammersmith Hospital Campus, Imperial College London, London, United Kingdom; From the Department of Chemical and Biomolecular Engineering and School of Engineering and Applied Science, Institute for Medicine and Engineering, University of Pennsylvania, Philadelphia; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia; and Department of Hematology, Imperial College, London, United Kingdom. Blood Sciences, Imperial College Healthcare NHS Trust St Mary's Hospital London UK; Centre for Haematology, Department of Inflammation and Immunity, St Mary's Hospital Campus of Imperial College Faculty of Medicine St Mary's Hospital London UK From the Department of Haematological Medicine, Guy’s, King’s, and St Thomas’ School of Medicine; and the Muscle Cell Biology Group, Medical Research Council, Imperial College School of Medicine, Hammersmith Hospital, London, UK. Centre for Haematology St Mary's Hospital Campus of Imperial College London, St Mary's Hospital Praed Street, London W2 1NY United Kingdom Centre for Haematology, Department of Medicine, Hammersmith Hospital, Imperial College London, London, United Kingdom; From the Dana–Farber/Boston Children’s Cancer and Blood Disorders Center and Harvard Medical School, Boston (R.F.G.), and Agios Pharmaceuticals, Cambridge (A.J.B., S.B., L.H., C.K., P.H., M.-H.J., C.B.) — all in Massachusetts; Hôpital Saint Vincent de Paul, Lille (C.R.), and Unité des Maladies Génétiques du Globule Rouge, Centre Hospitalier Universitaire Henri Mondor, Créteil (F.G.) — both in France; Hammersmith Hospital, Imperial College Healthcare NHS Trust, London (D.M.L.); Fondazione IRCCS Ca’ Granda... Department of Haematology Imperial College Healthcare NHS Trust, Hammersmith Hospital London UK 3West London Genomic Medicine Centre, Imperial College Healthcare NHS Trust, London, United Kingdom;; 5Centre for Haematology, Department of Immunology and Inflammation, Imperial College, London, United Kingdom; Imperial College London London UK |
Incoming Links
Total number of triples: 61.